Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y

Blood Platelets / drug effects Clinical Decision-Making Consensus Coronary Thrombosis / blood Cytochrome P-450 CYP2C9 / genetics Dual Anti-Platelet Therapy Hemorrhage / chemically induced Humans Patient Selection Percutaneous Coronary Intervention / adverse effects Pharmacogenomic Testing / standards Pharmacogenomic Variants Platelet Aggregation Inhibitors / administration & dosage Platelet Function Tests / standards Precision Medicine / standards Predictive Value of Tests Purinergic P2Y Receptor Antagonists / administration & dosage Receptors, Purinergic P2Y12 / drug effects Risk Factors Treatment Outcome
P2Y(12) receptor inhibitor genotyping platelet function testing thrombosis

Journal

JACC. Cardiovascular interventions
ISSN: 1876-7605
Titre abrégé: JACC Cardiovasc Interv
Pays: United States
ID NLM: 101467004

Informations de publication

Date de publication:
26 08 2019
Historique:
received: 01 01 2019
revised: 10 03 2019
accepted: 11 03 2019
pubmed: 17 6 2019
medline: 2 9 2020
entrez: 17 6 2019
Statut: ppublish

Résumé

Dual-antiplatelet therapy (DAPT) with aspirin and a P2Y

Identifiants

DOI: 10.1016/j.jcin.2019.03.034 PMID: 31202949
pubmed: 31202949
pii: S1936-8798(19)30831-3
doi: 10.1016/j.jcin.2019.03.034
pii:
doi:

Substances chimiques

P2RY12 protein, human 0
Platelet Aggregation Inhibitors 0
Purinergic P2Y Receptor Antagonists 0
Receptors, Purinergic P2Y12 0
CYP2C9 protein, human EC 1.14.13.-
Cytochrome P-450 CYP2C9 EC 1.14.13.-

Types de publication

Journal Article Practice Guideline Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1521-1537

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Auteurs

Dirk Sibbing (D)

Department of Cardiology, LMU München, Munich, Germany; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany. Electronic address: dirk.sibbing@med.uni-muenchen.de.

Daniel Aradi (D)

Heart Centre Balatonfüred and Heart and Vascular Centre, Semmelweis University, Budapest, Hungary.

Dimitrios Alexopoulos (D)

2nd Department of Cardiology, Attikon University Hospital, National and Capodistrian University of Athens, Athens, Greece.

Jurrien Ten Berg (J)

St. Antonius Center for Platelet Function Research, Department of Cardiology, St. Antonius Hospital, Nieuwegein, the Netherlands.

Deepak L Bhatt (DL)

Brigham and Women's Heart and Vascular Institute, Harvard Medical School, Boston, Massachusetts.

Laurent Bonello (L)

Department of Cardiology, Hopital Nord, AP-HM, Aix-Marseille University, Marseille, France.

Jean-Philippe Collet (JP)

ACTION Study Group, Institut de Cardiologie, Hôpital Pitié-Salpêtrière, Sorbonne Universite, Paris, France.

Thomas Cuisset (T)

Department of Cardiology, CHU Timone, and Aix-Marseille Université, Faculté de Médecine, Marseille, France.

Francesco Franchi (F)

Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida.

Lisa Gross (L)

Department of Cardiology, LMU München, Munich, Germany; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.

Paul Gurbel (P)

Interventional Cardiology and Cardiovascular Medicine Research, Inova Center for Thrombosis Research and Drug Development, Inova Heart and Vascular Institute, Falls Church, Virginia.

Young-Hoon Jeong (YH)

Department of Internal Medicine, Gyeongsang National University School of Medicine and Cardiovascular Center, Gyeongsang National University Changwon Hospital, Changwon, Korea.

Roxana Mehran (R)

Clinical Trials Center, Cardiovascular Research Foundation, New York, New York; Icahn School of Medicine at Mount Sinai, New York, New York.

David J Moliterno (DJ)

Gill Heart Institute and Division of Cardiovascular Medicine, University of Kentucky, Lexington, Kentucky.

Franz-Josef Neumann (FJ)

Department of Cardiology and Angiology II, University Heart Center Freiburg-Bad Krozingen, Bad Krozingen, Germany.

Naveen L Pereira (NL)

Department of Cardiovascular Diseases, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota.

Matthew J Price (MJ)

Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California.

Marc S Sabatine (MS)

TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Derek Y F So (DYF)

Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Gregg W Stone (GW)

Center for Interventional Vascular Therapy, NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, New York; Cardiovascular Research Foundation, New York, New York.

Robert F Storey (RF)

Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom.

Udaya Tantry (U)

Sinai Center for Thrombosis Research, Sinai Hospital of Baltimore, Maryland.

Dietmar Trenk (D)

Department of Cardiology and Angiology II, University Heart Center Freiburg-Bad Krozingen, Bad Krozingen, Germany.

Marco Valgimigli (M)

Department of Cardiology, Swiss Cardiovascular Center Bern, Bern University Hospital, Bern, Switzerland.

Ron Waksman (R)

Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC.

Dominick J Angiolillo (DJ)

Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida. Electronic address: dominick.angiolillo@jax.ufl.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Systèmes sanguin et immunitaire › Sang › Cellules sanguines › Plaquettes › Updated Expert Consensus Statement on Platelet...
questionsmedicales.fr › Diagnostic › Prise de décision clinique › Updated Expert Consensus Statement on Platelet...
questionsmedicales.fr › Phénomènes psychologiques › Processus mentaux › Pensée (activité mentale) › Prise de décision › Consensus › Updated Expert Consensus Statement on Platelet...
questionsmedicales.fr › Maladies cardiovasculaires › Maladies vasculaires › Ischémie myocardique › Maladie coronarienne › Thrombose coronarienne › Updated Expert Consensus Statement on Platelet...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Hémoprotéines › Cytochromes › Cytochrome P-450 enzyme system › Famille-2 de cytochromes P450 › Limonène hydroxylases › Cytochrome P-450 CYP2C9 › Updated Expert Consensus Statement on Platelet...
questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Association de médicaments › Bithérapie antiplaquettaire › Updated Expert Consensus Statement on Platelet...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Hémorragie › Updated Expert Consensus Statement on Platelet...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Updated Expert Consensus Statement on Platelet...
questionsmedicales.fr › Administration des services de santé › Gestion des soins aux patients › Sélection de patients › Updated Expert Consensus Statement on Platelet...
questionsmedicales.fr › Procédures de chirurgie opératoire › Interventions chirurgicales mini-invasives › Procédures endovasculaires › Intervention coronarienne percutanée › Updated Expert Consensus Statement on Platelet...
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Services de santé › Services de médecine préventive › Services de diagnostic › Dépistage génétique › Test pharmacogénomique › Updated Expert Consensus Statement on Platelet...
questionsmedicales.fr › Phénomènes génétiques › Variation génétique › Polymorphisme génétique › Variants pharmacogénomiques › Updated Expert Consensus Statement on Platelet...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents hématologiques › Antiagrégants plaquettaires › Updated Expert Consensus Statement on Platelet...
questionsmedicales.fr › Techniques d'investigation › Techniques de laboratoire clinique › Tests hématologiques › Tests fonctionnels plaquettaires › Updated Expert Consensus Statement on Platelet...
questionsmedicales.fr › Professions de santé › Médecine › Médecine clinique › Médecine de précision › Updated Expert Consensus Statement on Platelet...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Méthodologie en recherche épidémiologique › Valeur prédictive des tests › Updated Expert Consensus Statement on Platelet...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Agents neuromédiateurs › Agents purinergiques › Antagonistes purinergiques › Antagonistes des récepteurs purinergiques P2 › Antagonistes des récepteurs purinergiques P2Y › Updated Expert Consensus Statement on Platelet...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs aux neuromédiateurs › Récepteurs purinergiques › Récepteurs purinergiques P2 › Récepteurs purinergiques P2Y › Récepteurs purinergiques P2Y12 › Updated Expert Consensus Statement on Platelet...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › Updated Expert Consensus Statement on Platelet...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Mécanismes d'évaluation des soins de santé › Évaluation des résultats et des processus en soins de santé › Évaluation de résultat (soins) › Résultat thérapeutique › Updated Expert Consensus Statement on Platelet...